DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Gregory Renza - 2 Oppenheimer - 2 Jeff Jones - 2 Piper Sandler - 2 Edward Tenthoff - 2 Eli Lilly - 2 Dan Lyons - 2 Janus Henderson - 2
Top related locs:
Mariana Bristol Biopharma radiopharma New Jersey
Top related orgs:
pharma - 2 RBC Capital Markets - 2 TRT - 2 Novartis - 2 Mariana Oncology - 2 Janus - 2 Janus Henderson Investors - 2 AstraZeneca - 2

Search resuls for: "Andrew Tsai"


2 mentions found


☆ This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
  + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com   time to read: +7 min
RBC Capital Markets sees a $25 billion market opportunity for the space. The average analyst rating is hold, with 8% upside to the average analyst price target, according to FactSet. Eli Lilly has an average analyst rating of overweight and 8.3% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon AstraZeneca's one-year performanceAstraZeneca shares have an average analyst rating of overweight and nearly 6% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon Bristol-Myers Squibb's one-year performance
Persons: It's, Gregory Renza, Renza, Oppenheimer, Jeff Jones, Piper Sandler, Edward Tenthoff, Eli Lilly, Dan Lyons, Janus Henderson, Myers Squibb, William Blair, Matt Phipps, Jefferies, Andrew Tsai, They've, Janus Henderson's Lyons, Jones, Piper Sandler's Tenthoff, Myers Organizations: pharma, RBC Capital Markets, TRT, Novartis, Mariana Oncology, Janus, Janus Henderson Investors, Bristol, RayzeBio, Karuna Therapeutics, AstraZeneca, Fusion Pharmaceuticals, GlobalData's Pharma Intelligence, Pluvicto Locations: Mariana, Bristol
☆ A corner of the cancer therapy market is heating up—Here are the names investors need to know
  + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com   time to read: +8 min
A $25 billion market Meanwhile, RBC Capital Markets sees a $25 billion market opportunity for the space. A name Jones likes is Perspective Therapeutics , which he rates outperform. CATX 1Y mountain Perspective Therapeutics year to date Cantor Fitzgerald is also bullish on the name. So it's really an ideal profile," said Piper Sandler analyst Edward Tenthoff, who doesn't cover Perspective Therapeutics. Then there is Lantheus Holdings , which calls itself a radiopharmaceutical-focused company and has a $5.6 billion market cap.
Persons: There's, Eli Lilly, Myers, Jefferies, Andrew Tsai, radiopharma, Oppenheimer, Jeff Jones, FactSet, William Blair, Read, — it's, Andy Hsieh, Gregory Renza, Jones, Cantor Fitzgerald, Louise Chen, it's, Piper Sandler, Edward Tenthoff, Dan Lyons, Janus Henderson, Lantheus, Roanna Ruiz Organizations: Novartis, pharma, Mariana Oncology, Myers Squibb, AstraZeneca, Fusion Pharmaceuticals, RBC Capital Markets, TRT, Therapeutics, Alpha, Janus, Janus Henderson Investors, Lantheus Holdings, Lantheus, Leerink, ~$ Locations: Biopharma, Bristol, Mariana, radiopharma, New Jersey
0 next >>
Total: 2